The largest-ever federal action related to the U.S. opioid crisis is on the cusp of its first trial next week — and it's complicated. So here's a brief(ish) explainer breaking it all down.
State Attorney General Pam Bondi's office announced Friday that it had added the drugstore chains to a lawsuit filed in May against opioid distributors and manufacturers.
The company released a statement defending its pharmacist's right to decline to fill a prescription on ethical grounds. The state pharmacy board plans to investigate whether Arizona law was followed.
The lawsuit alleges the company fulfilled orders "for such large quantities of prescription narcotic pain medication that there could be no associated legitimate medical purpose for their use."
A journalist interviewing patients about medical tests that supposedly required only a few drops of blood ran into trouble with representatives from Theranos, the company behind the technology.
Walgreens was Theranos' largest revenue source. It cited problems that federal regulators have had with Theranos' lab testing in deciding to end the relationship.
The deal would unite two of the three largest drugstore chains in the U.S., creating a single company with nearly 13,000 retail outlets. but it will face intense antitrust scrutiny.
Hospitals are partnering with pharmacies to keep discharged patients from returning too soon. Walgreens, for one, is helping hospitals to manage patients' medications after they go home.